In This Article:
From what we can see, insiders were net buyers in Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.
While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.
View our latest analysis for Nautilus Biotechnology
Nautilus Biotechnology Insider Transactions Over The Last Year
The Co-Founder Sujal Patel made the biggest insider purchase in the last 12 months. That single transaction was for US$99k worth of shares at a price of US$2.89 each. That means that even when the share price was higher than US$2.27 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. It is encouraging to see an insider paid above the current price for shares, as it suggests they saw value, even at higher levels. Sujal Patel was the only individual insider to buy during the last year.
Sujal Patel bought a total of 50.00k shares over the year at an average price of US$2.81. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
Nautilus Biotechnology is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Insider Ownership Of Nautilus Biotechnology
Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Insiders own 32% of Nautilus Biotechnology shares, worth about US$92m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
What Might The Insider Transactions At Nautilus Biotechnology Tell Us?
It doesn't really mean much that no insider has traded Nautilus Biotechnology shares in the last quarter. But insiders have shown more of an appetite for the stock, over the last year. Insiders own shares in Nautilus Biotechnology and we see no evidence to suggest they are worried about the future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Nautilus Biotechnology. Every company has risks, and we've spotted 3 warning signs for Nautilus Biotechnology (of which 2 are a bit unpleasant!) you should know about.